AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06594601 — intervention group
Intervention type: PROCEDURE
Intervention: PEEP titration by 3D eit
Description: Patients were ventilated based on the ARDS-Net suggestions. The patients were kept at supine position. The PEEP titriatino by 3D EIT fwas as follows:~1. All patients were under pressure control mode (driving pressure 12-15 cmH2O with a tidal volume of 6-8 ml/kg predicted body weight, respiration rate12-15 bpm).~2. RM: PEEP was switched to a 21cmH2O for 2min, and FiO2 was titrated to obtain peripheral oxygen saturation (SpO2 ) ≥90%.~3. PEEP was stepwise decrease from 21 to 0 cmH2O PEEP in steps of 3cm H2O every 2min.~4. 3D EIT was used to monitor regional ventilation distribution during PEEP titration.
Study NCT06603038 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Gainful Daily Performance Greens
Description: Daily supplementation for 28 days
Study NCT06603233 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: The Difference Between The AI Model and Dentists Group
Description: The clinical feasibility of the best performing model, statistical hypothesis tests are performed that compares the predictions of the AI model with the assessments from three dentists.
Study NCT06603233 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Deep Learning Models
Description: DeepLabV3+, Mask R-CNN (Detectron2), YOLOv8, U-Net, Super Vision U-net and U-Net Transformer were trained on 354 images and tested on 79 images.
Study NCT06589232 — intervention group
Intervention type: OTHER
Intervention: Food allergy
Description: Threshold dose to pistachio
Study NCT06588114 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Antistress Ball
Description: Hemodialysis patients will be asked to look away by giving an antistress ball to the non-arteriovenous fistula hand and squeezing and then loosening the ball during the arteriovenous fistula intervention
Study NCT06588114 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: The Valsalva maneuver
Description: The Valsalva maneuver is a breathing method that can slow down a heart with a very fast pulse rate. In this maneuver, the individual breathes strongly through his mouth while his nose is tightly closed, and while holding his breath, a strong tension occurs. This maneuver allows the heart to react and return to a normal rhythm.
Study NCT06588114 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Skin cooling
Description: Hemodialysis patients will be provided with lowering of skin temperature with a skin cooling device by the researcher for 10 minutes before arteriovenous fistula intervention is made to hemodialysis patients
Study NCT06593509 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Maquet,Servo I.
Description: Model number: 06487800, Serial Number: 19761, SKU#: Inv-00344191, Made in Sweden
Study NCT06593509 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Vapotherm
Description: INC ,100 domain drive Exeter, NH 03833, Made in U.S.A
Study NCT06593509 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: venturi mask
Description: Intersurgical Ltd, Crane House, Molly Millars Lane, Wokingham, Berkshire, RG41 2RZ, UK.,REF. 1107085, LOT,31757961
Study NCT05523089 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Saline placebo
Description: Sterile normal saline for injection
Study NCT05523089 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: CD388
Description: CD388 liquid for injection
Study NCT06602895 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Intensive short-term functional strength training
Description: All players underwent a rigorous 2-week intensive short-term functional strength training program, with training sessions held for 5 days a week. One group engaged in intensive short-term functional strength training exercises, while the other group focused on balance training. The training regimen was then reversed for the two groups. Each daily training session lasted approximately 2 hours, with 1 hour of either intensive short-term functional strength training or balance training. Every intensive short-term functional strength training session spanned roughly 60 minutes, starting with a 10-minute warm-up followed by dynamic mobility exercises targeting key joints. During the 40-minute core segment of our intensive short-term functional strength training sessions, participants first engaged in stability exercises for 10 minutes, focusing on core stability and balance through plank variations and stability.
Study NCT06602895 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Balance Training
Description: Participants first engaged in stability exercises for 10 minutes, focusing on core stability and balance through plank variations and stability ball exercises. This was followed by 15 minutes of multi-joint strength exercises, where athletes performed compound movements like squats, deadlifts, push-ups or bench presses, and pull-ups or lat pull-downs, each for t sets of 8-10 repetitions. The session concluded with 15 minutes of agility and coordination drills, incorporating high-intensity activities such as lateral sprints and rope pulling, specifically designed to improve quickness and neuromuscular coordination, thereby enhancing overall athletic performance. The session concluded with a 10-minute cooldown involving flexibility exercises for the limbs and trunk. Exercise intensity was regulated to correspond with a 6-7 on the repetitions in the reserve-based Rating of Perceived Exertion (RPE) scale, where a s indicates that the exerciser feels they could perform approximately.
Study NCT05744752 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Lead Acetate
Description: The oral LD50 of lead acetate is 390mg/kg body weight. The experimental group B, C, and D will receive a single dose of 19.5 mg/kg b.w (1/120th of LD50),31 daily dissolved in distilled water and given by oral gavage method for 12 weeks. Lead acetate Pb(CH3COO)2x3H2O, will be purchased from Sigma-Aldrich Chemie (Germany).
Study NCT05491811 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ensartinib
Description: Participants will receive Ensartinib 225 mg oral once daily from baseline until disease progression, unacceptable toxicity, withdrawal of consent or death.
Study NCT05491811 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bevacizumab
Description: Participants will receive 7.5 mg/kg intravenous on Day 1 of 21 day cycles (every 3 weeks) from baseline until disease progression, unacceptable toxicity, withdrawal of consent or death.
Study NCT04810091 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Placebo Administration
Description: Given PO
Study NCT04810091 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire Administration
Description: Ancillary studies
Study NCT04810091 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Questionnaire Administration
Description: Ancillary studies
Study NCT04810091 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Telotristat Ethyl
Description: Given PO
Study NCT06601426 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: CSP
Description: cold snare polypectomy
Study NCT06601582 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Use of a operative blood salvage system
Description: The surgical team will use a operative blood salvage system
Study NCT06604663 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Activation of the CDSS system
Description: Activation of the CDSS system, whereby outreach workers and clinicians have access to and ability to act upon lists of patients who are at highest risk of missing their upcoming clinical appointment.
Study NCT06590012 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Participants will take the placebo capsules in addition to standard treatment for a year.
Study NCT06590012 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tertinat
Description: Participants will take Tertinat capsules in addition to standard treatment for a year.
Study NCT06595537 — intervention group
Intervention type: DEVICE
Intervention: Hand held ultrasound
Description: Determination of gastric feeding tube position with the use of Lumify handheld ultrasound
Study NCT06690359 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: IM19 chimeric antigen receptor T cell injection
Description: IgA nephropathy:~The investigators plan to recruit IgA nephropathy subjects with urinary protein and renal dysfunction who meet the inclusion and exclusion criteria. They will receive Beijing Zaimiao Biological IM19 CAR-T cell infusion therapy at doses of 0.5 × 10 \^ 8 and 1 × 10 \^ 8 CAR-T cells, with 3 subjects enrolled at each dose~Primary membranous nephropathy:~The investigators plan to recruit primary membranous nephropathy subjects who meet the inclusion and exclusion criteria and receive IM19CAR-T cell infusion therapy at doses of 0.5 × 10 \^ 8 and 1 × 10 \^ 8 CAR-T cells, with 3 subjects enrolled at each dose
Study NCT05908461 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Early Childhood Friendship Project
Description: Classroom-based intervention where teachers will implement 8 10-minute puppet shows, 7 5-minute active gross motor activities to reinforce the social skill of the week, and 7 5-minute passive rehearsal activities such as making their own puppet and practicing the steps of the week. Up to three 1 hour in vivo behavioral reinforcement periods will occur per week and during these free play sessions teachers and the main puppet will use developmentally appropriate praise to reinforce the use of the social skills of the week.
Study NCT05229887 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Nostril-Tragus-Length
Description: Endotracheal tube depth is determined by measuring the newborn's nasal septum-tragus length (NTL) and adding 1cm.~The NTL is described as the distance from the base of the nasal septum to the tragus of the ear.
Study NCT05229887 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Vocal cord marking
Description: The endotracheal tube has markings on the tube, which are called vocal cord markings, which will be used to provide a guidance to how deep to place the ETT into the trachea.
Study NCT05025020 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: interactive 3D tool
Description: The study tool displays 3-dimensional step-by-step animations of autologous and implant-based breast reconstruction procedures.
Study NCT05025020 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: BREAST-Q Reconstruction Module
Description: The BREAST-Q Reconstruction Module1-3 has 6 domains that cover various aspects of patient satisfaction and quality of life. BREAST-Q is part of our standard of care for patients treated for breast cancer and referred for reconstruction.
Study NCT05025020 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: BREAST-Q Reconstruction Module
Description: The BREAST-Q Reconstruction Module1-3 has 6 domains that cover various aspects of patient satisfaction and quality of life. BREAST-Q is part of our standard of care for patients treated for breast cancer and referred for reconstruction.
Study NCT05025020 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: DQI
Description: The DQI has 3 domains that cover decision-specific questions about what it is like for a patient to make decisions about reconstruction after breast cancer treatment.
Study NCT05025020 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: DQI
Description: The DQI has 3 domains that cover decision-specific questions about what it is like for a patient to make decisions about reconstruction after breast cancer treatment.
Study NCT05025020 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Ottawa Decision Regret Scale
Description: The validated Decision Regret Scale measures distress or remorse after a health care decision by the use of 5 items to indicate the extent to which the respondent agrees or disagrees with the statements in the regret scale.
Study NCT05025020 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Ottawa Decision Regret Scale
Description: The validated Decision Regret Scale measures distress or remorse after a health care decision by the use of 5 items to indicate the extent to which the respondent agrees or disagrees with the statements in the regret scale.
Study NCT06599775 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Adebrelimab injection
Description: Experimental group：Adebrelimab is an innovative PD-L1 inhibitor, monotherapy can improve pathological complete response rates with tolerable safety
Study NCT06599775 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Albumin-Bound Paclitaxel
Description: Experimental group：combined with Adebrelimab（PD-L1 inhibitor）,and carboplatin followed by endoscopic resection and subsequent simultaneous radiotherapy combined with albumin-bound paclitaxel and carboplatin
Study NCT06599775 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carboplatin injection
Description: Experimental group：combined with Adebrelimab（PD-L1 inhibitor），and albumin-bound paclitaxel followed by endoscopic resection and subsequent simultaneous radiotherapy combined with albumin-bound paclitaxel and carboplatin
Study NCT06702319 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise
Description: Home exercises and home exercises with internal focus exercises or external focus exercises
Study NCT06706284 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Semaglutide Injectable Product
Description: A GLP-1 inhibitor used to control T2DM
Study NCT06706284 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Saline solution will be administered with the same frequency as semaglutide and participants will be instructed how to use the saline in the same manner as the active drug group.
Study NCT06704165 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Orthodontic treatment using double slot bracket wire in high level slot
Description: patients will receives the new treatment therapy by using Double slot bracket with the wire in low level for the treatment of anterior deep bite .
Study NCT06704165 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Orthodontic treatment using double slot bracket with wire in low level slot
Description: patients will receives the new treatment therapy by using Double slot bracket with the wire in high level for the treatment of anterior deep bite .
Study NCT06704659 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Breast conserving surgey and radiotherapy
Description: The patients will undergo repeat Breast Conserving Surgery and Radiotherapy
Study NCT06704659 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Mastectomy
Description: The patients will undergo mastectomy
Study NCT06305364 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Gixam
Description: Participants will be required to extend their tongue in the Gixam device. Six images will be obtained and analyzed by the artificial intelligence (AI) model generating a prediction score for the presence of colorectal adenoma.
Study NCT06519942 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Blood sampling
Description: Fasting blood samples will be obtained.
Study NCT06519942 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Electromyoneurography (EMNG)
Description: Nerve conduction of sensory and motor nerves of the upper and lower limb will be performed, including F- and H-waves. Needle EMNG of the m. tibialis anterior, m. gastrocnemius (medial head), m. tensor fascia lata and m. gluteus maximus) will be performed.
Study NCT06519942 — intervention group
Intervention type: PROCEDURE
Intervention: Muscle biopsy
Description: Muscle biopsy of the m. gastrocnemius will be performed under local anesthesia using the modified Bergström technique.
Study NCT06519942 — intervention group
Intervention type: RADIATION
Intervention: Quantitative peripheral computed tomography (qPCT)
Description: A qPCT scan of the calf will be performed.
Study NCT06519942 — intervention group
Intervention type: DEVICE
Intervention: Mechanography
Description: Single two leg jump, multiple one leg hopping, chair rise and sit to stand tests will be performed.
Study NCT05744752 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Lead Acetate
Description: The oral LD50 of lead acetate is 390mg/kg body weight. The experimental group B, C, and D will receive a single dose of 19.5 mg/kg b.w (1/120th of LD50),31 daily dissolved in distilled water and given by oral gavage method for 12 weeks. Lead acetate Pb(CH3COO)2x3H2O, will be purchased from Sigma-Aldrich Chemie (Germany).
Study NCT05744752 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Lead Acetate
Description: The oral LD50 of lead acetate is 390mg/kg body weight. The experimental group B, C, and D will receive a single dose of 19.5 mg/kg b.w (1/120th of LD50),31 daily dissolved in distilled water and given by oral gavage method for 12 weeks. Lead acetate Pb(CH3COO)2x3H2O, will be purchased from Sigma-Aldrich Chemie (Germany).
Study NCT05744752 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: OTHER
Intervention: Moringa oleifera Extract
Description: The method described by Hanaa Elgamily(32) with minor modifications. Fresh Leaves will be washed and dried in dry heat oven. All the preparation will be done in pharmacological department, University of Health Sciences in sterile environment. Dried leaves will be crushed to make fine powder. 1000 g powder of MO will be socked in 5000 ml of 70% ethanol (70% ethanol and 30% distilled water) for 72 hours at room temperature. Then mixture will be magnetically stirred for 24 hours and stored at 4oC for 48 hours to allow extraction of active ingredients. Then the mixture will be filtered twicely by using Whatman No 1 filter paper. The extract will be concentrated by rotary vacuum evaporator at 40 oC to evaporate the solvent. The extract will be freeze, dried and stored at -70 oC for use. Dose of MO extract will be 400 mg per kg.(33) body weight given daily in 1ml of distilled water by oral gavage method for 12 weeks.
Study NCT05744752 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Moringa oleifera Extract
Description: The method described by Hanaa Elgamily(32) with minor modifications. Fresh Leaves will be washed and dried in dry heat oven. All the preparation will be done in pharmacological department, University of Health Sciences in sterile environment. Dried leaves will be crushed to make fine powder. 1000 g powder of MO will be socked in 5000 ml of 70% ethanol (70% ethanol and 30% distilled water) for 72 hours at room temperature. Then mixture will be magnetically stirred for 24 hours and stored at 4oC for 48 hours to allow extraction of active ingredients. Then the mixture will be filtered twicely by using Whatman No 1 filter paper. The extract will be concentrated by rotary vacuum evaporator at 40 oC to evaporate the solvent. The extract will be freeze, dried and stored at -70 oC for use. Dose of MO extract will be 400 mg per kg.(33) body weight given daily in 1ml of distilled water by oral gavage method for 12 weeks.
Study NCT05744752 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Allium sativum Extract
Description: Fresh Allium sativum bulbs will be selected for study. The cloves will be peeled, washed with distilled water and dried under shed. Then it will be chopped into small pieces. 1000g of chopped garlic will be crushed by mortar and passel. The garlic paste will be mixed with 5000 ml of 70% ethanol (70% ethanol and 30% distilled water) for 72 hours at room temperature. Rest the procedure is same as mentioned in moringa extract. Dose of 500 mg per kg(34) body weight garlic extract will be given daily in 1ml of distilled water.
Study NCT05744752 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Allium sativum Extract
Description: Fresh Allium sativum bulbs will be selected for study. The cloves will be peeled, washed with distilled water and dried under shed. Then it will be chopped into small pieces. 1000g of chopped garlic will be crushed by mortar and passel. The garlic paste will be mixed with 5000 ml of 70% ethanol (70% ethanol and 30% distilled water) for 72 hours at room temperature. Rest the procedure is same as mentioned in moringa extract. Dose of 500 mg per kg(34) body weight garlic extract will be given daily in 1ml of distilled water.
Study NCT05744752 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Placebo
Description: 1ml NaCl 0.9% daily for 12 weeks
Study NCT05126082 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: PedsBP CDS
Description: The PedsBP CDS is a sophisticated web-based electronic health record (EHR)-linked tool that can be used to address barriers and improve the identification and management of elevated blood pressure (BP) and hypertension (HT) in children and adolescents by providing patient-specific clinical care recommendations in real time and in accordance with national guidelines for BP management in youth.
Study NCT04714476 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Made-to-measure compression garment
Description: Subjects will wear one of two made-to-measure compression garments:~(1) JOBST® Confidence leggins (BT) and (2) JOBST® Confidence Bermuda (ET)
Study NCT05557227 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 1-hour cycling
Description: 60 % VO2 max
Study NCT06519942 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Electrocardiography (ECG)
Description: A 15-minute resting ECG will be performed.
Study NCT06519942 — intervention group
Intervention type: OTHER
Intervention: Questionnaires
Description: Questionnaires will be performed to collect information on medical background (drug use, comorbidities, symptoms of peripheral neuropathy, ...) and lifestyle factors (ethyl consumption, food intake, physical activity, smoking).
Study NCT06519942 — intervention group
Intervention type: OTHER
Intervention: Anthropometry
Description: Length and hip:waist ratio will be measured. Furthermore, body weight and composition will be determined by bio-impedance measurement. Systolic and diastolic blood pressure (mean of 3 times) will be evaluated.